The Administrative Appeals Tribunal has granted pharmaceutical company Aspen Pharmacare a legal stay against the Therapeutic Goods Administration’s (TGA) ban on some of its products. The company took…

Boehringer Ingelheim, manufacturer of the expensive anti-clotting drug dabigatran, has initiated a lobbying campaign to get it listed on the Pharmaceutical Benefits Scheme (PBS). The company’s efforts…

Any parent who watches kids' weekend footy knows that if the ref misses a breach of the rules, merry hell breaks loose. But referees are human and sometimes make errors. We forgive the odd one pretty…

In an attempt to contain growing health costs, the Australian Government has resisted recommendations to subsidise the pain medication Targin on the Pharmaceutical Benefits Schedule. Not only is this…

The fanfare around Health Minister Nicola Roxon’s announcement yesterday that the government would fund 13 new medicines on the PBS is a reminder of the power and influence involved in the selection and…

Federal and state governments in Australia appear much less successful than their United States counterparts in recovering taxpayers funds lost to suspected large-scale corporate fraud. For instance…